Overview of side effects of budesonide delayed-release capsules

Budesonide delayed-release capsules, as a drug for the treatment of primary immunoglobulinA nephropathy (IgAN), can effectively slow down the loss of renal function, but may also be accompanied by a series of side effects. These side effects cover the nervous system, digestive system, cardiovascular system, skin system and immune system.

First, patients may encounter some common side effects when using budesonide delayed-release capsules. These include, but are not limited to, headache, dizziness, indigestion, nausea, vomiting, stomach pain, bloating, flatulence, and constipation. These symptoms of discomfort in the digestive system are likely to be caused by the irritation of the gastrointestinal mucosa by the drug. At the same time, patients may also feel tired and weak, which may be related to the overall effect of the drug on the body. In addition, some patients may also experience symptoms such as high blood pressure, back pain, muscle spasms, or joint pain. These symptoms may be related to the imbalance of electrolytes in the body caused by the anti-inflammatory effect of the drug.

In addition to the common side effects mentioned above, budesonide delayed-release capsules may also cause some more serious side effects. Long-term use of this drug may lead to high levels of corticosteroids in the blood, leading to hypercortisolism. Symptoms of hypercortisolism include acne, increased or thicker body and facial hair, easy bruising, a fat pad or peak between the shoulders (buffalo hump), a round face (moon face), and pink or purple streaks on the skin of the abdomen, ankles, thighs, breasts, or arms. The occurrence of these symptoms indicates that the cortisol level in the patient's body is too high, and medical staff need to be informed promptly so that the treatment plan can be adjusted.

In addition, long-term use of budesonide delayed-release capsules may cause adrenal suppression. Adrenal suppression refers to the inability of the adrenal glands to produce enough steroid hormones. Symptoms include fatigue, nausea, vomiting, weakness, and low blood pressure. Patients should also inform their healthcare provider immediately if they experience increased stress or experience any symptoms of adrenal suppression during treatment.

It is worth noting that budesonide delayed-release capsules may also weaken the patient's immune system and increase the risk of infection. Therefore, during treatment, patients should avoid contact with people who have infectious diseases, such as those with chickenpox or measles. If you are exposed to someone with these infectious diseases, your healthcare provider should be informed immediately. In the meantime, patients should also consult with their healthcare provider to develop an appropriate vaccination plan to prevent possible infection.

In addition, patients may experience rare side effects, such as allergic reactions, while using budesonide delayed-release capsules. Signs of an allergic reaction include hives, difficulty breathing, and swelling of the face, lips, tongue, or throat. Once these allergy symptoms occur, patients should seek emergency medical attention immediately.

In summary, budesonide delayed-release capsules are effective in treatingIgAN, but they may also cause a series of side effects. When using this drug, patients should fully understand its possible side effects and use the drug rationally under the guidance of a doctor. During treatment, patients should pay close attention to their physical condition. If they experience any discomfort or abnormality, they should promptly inform medical staff so that the treatment plan can be adjusted.

Reference materials:https://www.drugs.com/history/tarpeyo.html